Clinical Trial Update: Outcome of Moderate Severity in OPC Poisoning Patients When Treated With Pralidoxime [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pralidoxime for moderate organophosphate poisoning reports the outcomes of treatment in this condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Organophosphate Poisoning

Drugs mentioned

• Pralidoxime (pralidoxime)

Snippet

Sponsor: Sir Salimullah Medical College Mitford Hospital | Conditions: Organophosphorus Poisoning | Phase 2 | Status: COMPLETED